The Cost-Effectiveness Of Tavi In Intermediate Risk Patients In France
Abstract
Authors
G Goodall P Candolfi B Zemanova A Sohlberg
G Goodall P Candolfi B Zemanova A Sohlberg
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now